Bristol-Myers Squibb Company (NYSE: BMY) is included among the 12 best shares to buy now for passive income.
Bristol-Myers Squibb Company (NYSE: BMY) is a global biopharmaceutical company in which many consider it worth investing and maintaining in the long term. Its history dates back to early 1800, made up of decades of drug innovation and strategic mergers. Today, the company focuses on treatments in oncology, cardiovascular health, immunology, neuroscience and blood disorders.
In recent years, Bristol-Myers Squibb Company (NYSE: BMY) has invested approximately $ 100 billion in acquisitions to prepare for losses of key medication income that are approaching the expiration of patents.
Bristol-Myers Squibb Company (NYSE: BMY) is a solid dividend company. On September 17, the company declared a quarterly dividend of $ 0.62 per share, which was in line with its previous dividend. In general, it has a 16 -year -old dividend growth history, which makes it one of the best actions for passive income. As of September 22, the action has a dividend yield of 5.51%.
While we recognize BMY’s potential as an investment, we believe that certain AI actions offer greater upward potential and have less downward risk. If you are looking for an extremely undervalued action that also benefits significantly from the Trump era tariffs and the wave trend, see our free report on the The best short -term AI actions.
Read below: 12 best retail dividend shares to buy now and 11 cheap quarterly dividend shares to buy right now
Disclosure: None.
(Tagstotranslate) Bristol-Myers Squibb Company (T) Biopharmaceutical Company (T) Passive income
Source link